NDC 62756-072
Ganirelix Acetate
Ganirelix Acetate
Ganirelix Acetate is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is Ganirelix Acetate.
| Product ID | 62756-072_482153ed-785f-4eb0-9e22-3a608fd0dcc4 |
| NDC | 62756-072 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ganirelix Acetate |
| Generic Name | Ganirelix Acetate |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2019-11-07 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA204246 |
| Labeler Name | Sun Pharmaceutical Industries, Inc. |
| Substance Name | GANIRELIX ACETATE |
| Active Ingredient Strength | 250 ug/.5mL |
| Pharm Classes | Decreased GnRH Secretion [PE],Gonadotropin Releasing Hormone Antagonist [EPC],Gonadotropin Releasing Hormone Receptor Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |